Dr. Timothy Banister is a pharmacist who is specialized in Oncology in Bedford, Texas. Patients can reach him at 1609 Hospital Pkwy, Bedford or contact him on 817-359-9070. Active license number of Dr. Timothy Banister is 33742 for Oncology in Texas. Dr. Timothy Banister is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Timothy Banister speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Timothy Banister
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Male
Location:
1609 Hospital Pkwy, Bedford, Texas, 76022-6920
Phone:
817-359-9070
Fax:
817-359-9025
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Timothy Banister are as mentioned below.
NPI Number:
1831192442
NPI Enumeration Date:
27 May, 2005
NPI Last Update On:
21 Jun, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Timothy Banister are as mentioned below.
Specialization
License Number
State
Status
Oncology
33742
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1609 Hospital Pkwy, Bedford, Texas
Zip:
76022-6920
Phone Number:
817-359-9070
Fax Number:
817-359-9025
Patients can reach Dr. Timothy Banister at 1609 Hospital Pkwy, Bedford, Texas or can call on phone at 817-359-9070.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.